Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis. [PDF]
Lv H, Yang X, Liu Y, Zhou J, Yu W.
europepmc +1 more source
Therapeutic functions of tanshinone IIA in a zebrafish model of glucocorticoid-induced osteoporosis. [PDF]
Li X +9 more
europepmc +1 more source
Tanshinone IIA inhibits epithelial-mesenchymal transition in ovarian cancer by promoting NR3C2 transcriptional activation of ING1. [PDF]
Wang X, Zhang D, Wang T, Li X, Zhang J.
europepmc +1 more source
Research progress on the molecular mechanisms of tanshinone IIA in the treatment of cardiovascular and cerebrovascular diseases (Review). [PDF]
Pei W, Lu P, Ding C, Li Y, Li Y.
europepmc +1 more source
Tanshinone IIA inhibits foam cell formation and alleviates atherosclerosis by regulating the Hedgehog signaling pathway through TRPM2 suppression. [PDF]
Yin Y +12 more
europepmc +1 more source
Tanshinone IIA accelerates zebrafish venous vascular repair via macrophage recruitment through the CXCR4A-CXCL12B signaling axis. [PDF]
Zhang L +8 more
europepmc +1 more source
Physiologically Based Pharmacokinetic-Pharmacodynamic-Based Quantification of Exposure-Response for Sodium Tanshinone IIA Sulfonate in Normal and Cerebral Ischemia-Reperfusion Injury Rats. [PDF]
Chen Y +8 more
europepmc +1 more source
Targeting Skp2 by Tanshinone IIA overcomes chemoresistance in colorectal cancer. [PDF]
Dong X +10 more
europepmc +1 more source
Tanshinone IIA prevents septicemia acute kidney injury via regulating the DUSP10/JNK/P38/NLRP3 pathway. [PDF]
Wen D +7 more
europepmc +1 more source
Protective effect of tanshinone IIA against Listeria monocytogenes infection in vitro and in vivo. [PDF]
Wang H, Hu S, Feng H, Sun H.
europepmc +1 more source

